Despite a general consensus among the scientific community that current research is not enough to produce a “cure” for Ebola, startups and scientists all over the world are seemingly racing against one another to find marketable medication for the disease. San Diego-based Mapp Biopharmaceuticals has been ramping up production of now well-known ZMAPP, the drug administered to at least two …
Read More »